[ad_1]
The Advisory Council of the World Health Organization states: The benefits of the vaccine outweigh the risks. The data gave no indication of an increased risk of blood clots.
After the European Medicines Agency (EMA), the World Health Organization (WHO) reiterated their recommendation for the AstraZeneca corona vaccine. The benefits of the preparation outweigh the risks, which he explained WHO-Vaccine Safety Advisory Council on Friday. The vaccine has “enormous potential to prevent infections and reduce the number of deaths worldwide.”
From the available data, there is no evidence of an increased risk of “deep vein thrombosis or pulmonary embolism” as a result of vaccination with the AstraZeneca vaccine, explained the WHO-Experts. They also found no evidence that the rare and dangerous clots in the brain that occurred after the AstraZeneca vaccines were caused by the injection, according to their own reports. the WHOThe advisory panel recommended that medical personnel be alerted to signs of serious side effects in vaccinated individuals.
On Thursday, the EMA had already given the green light for the further use of the AstraZeneca vaccine. Germany and other European countries then resumed vaccinations with the British-Swedish manufacturer’s vaccine. Denmark and other Scandinavian countries, on the other hand, are more cautious and don’t want to use AstraZeneca again just yet.
(APA / AFP)
